Visterra
Visterra
Develop precision antibody based biological medicines
Human health & social work | United States of America | Access to Information |
Profile Provided By: Company Website
Overview
Visterra is a clinical stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer precision antibody based biological medicines for infectious and non infectious diseases.
Industry |
Legal Structure |
Operating Status |
Employees |
| Human health & social work | C Corporation | Operating | 11 - 50 employees |
Funding and Financing Rounds
Jun, 2016 / $21,1M / Series C + / Equity
Oct, 2014 / $30M / Series B / Equity
Dec, 2013 / $8,1M / Series A / Equity
Sep, 2012 / $26,1M / Series A / PRI / Equity
2010 / $6M / PRI / Debt
2008 / $2,04M / Seed / PRI
Team
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
- Social Policies and Performance
Impact Reports & Metrics
Offices
Headquarters
One Kendall Square
Suite B3301
Cambridge, Massachusetts 02139
United States of America